ENCLEAR THERAPIES, INC.
Last verified 2026-05-02. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $3.0Mattributed |
|---|---|
| Latest round | grant, $3.0M, 2025-01-01attributed |
| Founded | unknown |
| Headquarters | Newburyport, Massachusetts |
| Industry | unknown |
| Stage | unknown |
| Website | encleartherapies.com |
EnTrega CSF delivery platform for closed-loop cerebrospinal-fluid dosing of CNS therapeutics. Sold to neuro-oncology, neurodegenerative, and lysosomal-storage clinical programs. Combines mechanical CSF control with ML-driven dose tuning.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-01-01 | grant | $3.0M | undisclosed |
Detected tech stack
Google Cloud CDN, Sentry, Vercel Speed Insights, WebsiteBuilder, Wix, Google Cloud, React, lodash .
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $3.0M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $3.0M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | encleartherapies.com, read 2026-05-02 |
| Description | self-reported | encleartherapies.com, read 2026-05-02 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.